Form 4: Marimed COO Timothy Shaw Reports Stock Transactions
SEC Form 4 Filing
Marimed's Chief Operating Officer, Timothy Shaw, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- Timothy Shaw, the Chief Operating Officer of Marimed Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 7, 2024, 43,333 Restricted Stock Units (RSUs) vested and converted into common stock on a one-for-one basis.
- Also on March 7, 2024, Mr. Shaw sold 15,348 shares of common stock at a price of $0.2348 per share.
- The sale was executed pursuant to a pre-existing Rule 10b5-1 trading plan adopted on March 10, 2023, to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Mr. Shaw directly owns 8,477,072 shares of Marimed common stock.
- He also has indirect ownership of 2,000,000 shares held by the Shaw Family Trust, for which he disclaims beneficial ownership.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity related to RSU vesting and tax obligations, which is neither particularly positive nor negative.
Future Outlook
The remaining RSUs will vest in two tranches of 21,667 RSUs each on September 7, 2024, and March 7, 2026.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.
Stakeholder Impact
- The sale of shares by an insider could have a minor negative impact on shareholder sentiment, although it is mitigated by the fact that it was pre-planned and for tax purposes.
- The vesting of RSUs is a form of compensation for the COO, aligning his interests with those of the shareholders.
Next Steps
- The remaining RSUs will vest on September 7, 2024, and March 7, 2026.
- Further Form 4 filings may be expected as these RSUs vest and shares are potentially sold to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2023/03/10 | Rule 10b5-1 instruction letter previously adopted by the Reporting Person |
| 2024/03/07 | RSUs convert to shares of common stock on a one-for-one basis |
| 2024/03/07 | Shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person |
| 2024/03/08 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.